Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways ; volume:29 ; number:1 ; day:11 ; month:9 ; year:2023 ; pages:1-17 ; date:12.2023
Molecular medicine ; 29, Heft 1 (11.9.2023), 1-17, 12.2023

Creator: Khuanjing, Thawatchai
Maneechote, Chayodom
Ongnok, Benjamin
Prathumsap, Nanthip
Arinno, Apiwan
Chunchai, Titikorn
Arunsak, Busarin
Chattipakorn, Siriporn C.
Chattipakorn, Nipon

Contributor: SpringerLink (Online service)

DOI: 10.1186/s10020-023-00686-7

URN: urn:nbn:de:101:1-2024020808532686646294

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Khuanjing, Thawatchai
Maneechote, Chayodom
Ongnok, Benjamin
Prathumsap, Nanthip
Arinno, Apiwan
Chunchai, Titikorn
Arunsak, Busarin
Chattipakorn, Siriporn C.
Chattipakorn, Nipon
SpringerLink (Online service)

Other Objects (12)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario

Hochschulschrift

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario

Hochschulschrift

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario

Hochschulschrift

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

Exploring an novel diagnostic gene of trastuzumab-induced cardiotoxicity based on bioinformatics and machine learning

The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity

Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)

Related objects

Reset password